<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Glycemic control in type 2 diabetes</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Glycemic control in type 2 diabetes</h1>
<div class="graphic"><div class="figure"><div class="ttl">Glycemic control in type 2 diabetes</div><div class="cntnt"><img src="data:png;base64,iVBORw0KGgoAAAANSUhEUgAAAdAAAAF0CAMAAACkDpjKAAAACXBIWXMAAAPoAAAD6AG1e1JrAAAAYFBMVEX/////GBjY3ur/cnLy8PKvv98yW60AAAD/AAAAM5lhgcClpaVycnL/QUEzMzMTQqGIiIhPcrnIyMifstkREBG/zOX/xsb/paVUVVUhISKGns//iIhERET/39+wOVjQAACex8MuAAAT4ElEQVR42uydB5ujOAyGKQ6G0EsggWTv///LM6TRTIbExgXp2b2bCdk273yyJMuyYYCBgYGBgYGBgYGBgYGBgYGBgYGBgW1gplvCF0GwNbbruuHtb2+uXJP8CjcUCzS7YnzNAN0CA9teAVS4Qi84y/AF0M1a+URUmUSoyAjdkPxAnQpN94ZCot/GsNtXzbIkn7h2+6x93axawHb7vOoebAQ0w4VhRNgHeLMe9+E/W+1V5OOQcAndBpkmun9atpQI0Bbq2+WSt5CfFfkcPVSLTLfaBqiFcUaAJgBvCahNQCLXvd1JtVAr8uPmdta0MJseUPL6rf0l7edEtgjZ3dt6QLsXXJvL39kv8OXyUih+GsDsu9wxUCJP0zQ6cN3TZaDhQ7QvoOb9O+HDkvu9oQJbo5cA6N1aeiQoervcO9AWid0+JQIOqyfQcupyH0CJk+4Btd2n8dGoccWBAUDn7ZG2vIKiB1DyMoGD7k+fQMmjcVDUASW/2OwDdd/G4W8cYHyZrqAAlKPxBTpvAJTnwvy2EoCCQgEoAAWg3AMtrlEuAN3YeOehAFSMRm0DgIIBUJWs6pyxWQFQPVyrzS9YAqACgp/mnc40AFRCJa5NT8w3UBOASqjEtQUEl2PFAYAyKBQAUEWNwmF1ER6Ayg10tUJhDZXDqEpcCxSiXMkVuroID3mo3EDXF+GhUiR1lCuiCA9AOeahMhkA/UKjtgFAwQAoGAAFA6AAFAyAggFQMAC6q3QTgK4xBQpCAHS1PhXVKACdmogzRgAUgALQP5qQc7oAFBQKQAEoRLkAVIsCAuShuhUQoFIErhWAQvADQAEoANW2gABAQaG62w2AamWNGUKUq2adYO7BLTRLpQsIewBK5TN90LgNUruAsAOg1DrB5EEZhtpefaQRUGqMM3qAbLMxDACqC9DS/OuNWABUzjrB4AEKeRybBqCcFXqjPajMEBkAVDmgrl3OPzC1vwdSH6C39/QfGzVmWM1EubrLUyeglWn3001UmWaFPiWoAFSqlLOXbqK28DN6uQrNBlHeD0ClsoniyvlYp7Rd+/Z8w80wAKjM+uxpjl4puNlmWGpeSlAf6KiCsFzIa+Oj3chTC6DNR/U1AksJB8fzPOcwftlKycteagFQY1r5kTm1PHrp4XRIvePw5dxz8tMpd7wcgA4VWkpS+aEI8fAglnuDR6cn4KN3AqDDklAlsxAN5/lC6gxedqYfLUQBCGkO9B3lmnIEOxQhGsbr84M3+/Lo9TlLIoxxFCCdgUpX+aEI0bBeHvXk9eOft6M9fQCaXQjNiDAtEp2Bylb5oQiRgUKjImi/E1BywUhnoG2p1pam0E4TIpFu+uMaGjx/PxRoDBRVoRvKtE1NVShEuX+lKdc2GEWIr/D3+EMemkXkP/5VU6DCac7nm9Qo9/dKEfIxSVt8rGOUK4E2afkmRYgM/s34boV2CpXC09KVSBEiK6B/TloUASrLuknLN3n+07NIn0rRI9sUQXNecdRoli/TVUQlBvpq+tpem/NrJT3f5Inz2vrcSAOgAkda0NZKEQpNsC5ABR7Hpa2V9HyTJ9BME5crEChNiQv5JjezCk2AChxpQV8rueWbdPOpLje7zuUz+1YoJX2kr5W88s1vgF6w3/0EoB+CWTFr5WLWMutyC5wQoBlEuZ+XRBFr5TfaPbdMlQGKXN59CfTCj4C1kmrZOcquwcyDoDDQpXgqFD9NWqBhyLsvYSGt3H6tpEe5GPvJZQZ0W7EPcKCKQiuTd31ISOFntQWFj/257bOMgDaiic+VFehtg5PzYkqza4FGiCh0bj/Uj1RKW8IN6n1SBbMLoQ++Fsp3LDRbNMSrEcwG7X5opjjQcpvikEzBLF2ifpAkluJAw02Ocx7iozTB7ILLJcvkVfHdFjvcIs9NY6lJvjwuevxHIaCjhLNkfmQl75SYD+WZjr5IdduIV78X2Jj2u6Xvd20BlKyfZ7WAjo6qIOYZC1klT6dTf62clSfyPGT8AeimluFLQOJclVzuew7x3dOGrB1u/aggnF7KmsrzBZSAPBKhWne5tqpN2wd1TP7ffRq3Cq3bz2LPQmlf1RDldjbaVmFfIoqfX/E6Xlw9n0BRq85OoTWBRfCRBwcUe6facx4uF8UxygnUlHyvxOzPM/T/Un4SrAhy5QN6Y3/Evlfio8uzB9Qg8uygElZdgzt5YJGPDzlZiGurW0NTL0+9Q6djvhLNJjueigHlUCIaAF0IbueA5o8HHVCjJt7Ys1qgBy+NuzdyrwJHvmotKAOgDYeMpe9yqfIcAz3dXa6DjLp+ATU6hF2UG3fCdNq1NOWZ/vjqdf31gyIuJaJeULSUe97TlidQ4lTboIhwiw9PoF1MlN/TFvIx+V3RkdN0GpWB9tIWxKdE9Exb0gV5SmtIwc75V2GBV4noXlg4KlEa+tGkKv1VPKeaHFSUp7HQgiI/UMRzU7tWVJ7UFhQFgIb8avIodSwledJbUOQH2vDrIrIcR9Xh5PQWFNmB3vhNYTzFR0NVU7cFhd+mdh3nhrqmagsKv03tY2wZKltyUaw431nJxOHO9EcjdZfP+9+/PcF9UU6hiMlQ+JnDR5bCy+ddn7iILli5NZSJw51py8y93FAdqKVcCwqrTe3p4SPVl0/jcYKb5C5IJaA2mxLR+GgDWT6V5/nYbSGmzjROFLK5hWN8+IgsnxpcdaYe0JLZ5NuhQvO4NnQw9DBVXG7DriI/OHxU72GvTD6gTK9d6UW56hbjh6baRGvG1668Dh9ZTqrHTaGSz5wfn7GvWN8x96gUHTRZPmW/FWJ85MHmtL+idjF+XFiIClnvbRnNqSlDPod6kQbVhHGcK2dQNGyorkw+h+4txYvxCkW5A6A2p/4h5Yvx6gDtT2OsQk5XtKpfjFdToZzcraHd8qkKUD7uFmm4fAZtR64f+DIC5T2NUcfl0+9GvyFJm8T43hKZa1NN6AsUW/f/ic1DaVMXeU5jPMYnQ0egSAKgdCVyKw5psZc9Y0k3nBFdhB6FoK+VvIpDhjbF+Mk3aoGvQXDBQg8rUWeLM6/Fa7183i0r2m6FM5IRKK/ikN7VBJQEQbbi/eyBUu7nQLyKQ0Sf++xNEKvQkldxiPDUvzp0lm4N5eZuded5bxCLhA7NmEa5xN2yzVbeZ1g05/ls4hQ7BWWchzLuHOqfYdHd396DXOFjbYYVocZl3Tn06u6rtV8/Eyze5Y4WAfbFod4ZFu3joaxDGcgzBYVHcUiJ6zk0Slv6xqM4pMYFOoz/zZIA5VOL35tCs0SSNfTGqTikxAU6zLSZXGUZ3sitOKTGBTpscJ67rCWRYQ3lVxxS4wIdVoWFyPfXDLXmBZR5cWhIVP4LdJgBxdFZAqDsTvHOfbOk+2mOz4JLyzQRDJR5cWjAc2eHHbJzITgo4tY5tEuenecVqlBunUMPnumuDyNtD5RhcchKvfGMfuQcAdqmQBm629xz8tMpd3otQ8BzY6Asi0OnZ555fBVvd8lT5K0QTItDjjP+aI88u2mcoqJctsWhd2HvNepth/pMxHUssC4OvS/9u19Ct8/D2QnOBLlc5sWhkUJ3eti+m8YpAij74tBwDd3r8ARBd58xHfE2F+Va8U6HJ4gByqc41MtDd8tTzGV2vI6VvSpFO+Zp+AGxZFOgPxeHDh+2N/fMM9vc5d5+drczlzkAz3facsXBl7cTHtb2AdiPe3l/1OeHFqHDnnkaQZThzP9qCsonoUyM0VST6WUOo9Bo18PB2svszrPXfBSz/WP4z0Kh6PP3uSbLbbbHeN/D3nycnTHtIh6ywGZUoB+EMjXqLIWVoexSI7zlOHsf9oYMlCSUKOWMz3SXu7ofnRHQpT84j2H7cyEPnRHoG+jqEyOUWQpfrKG0Rnik5zCpNRZFS5WiqCdQPLGeUPAfrPivBxT/YufX4n0e/gmeh/W3H4D6MwLtr6HpI8z595c1tDIbVi6X0giv8fAhRi43mptH1Y9yqWnIdEZfWxxiN11z7tpPcLdvnPNAfVygxTz0Hw3QBPSjOMRxuqYVO9Cs2YnwhxkL1AlgY9Cv+f/cpmvWHrhbfkDHr3M8VvZwMylMGn99Lfx2asZXg6eoacgQKN9jZXd3C73xbwvaSDYoGCp0CJrrsTJwt1NL8CUICpZAB6833N2tA+52aNd1R7jxXPDjmnY1B9T8tXPo4wbdSYtbedmav2q+Kp5NT0rbNMMKjUH/OuLt4wZdHecAcGTZOcq+3OAepCG3JnTD5tYH/Wuj5qcNOgRbKzMhYoGxn3w7c/4QD77AVWiadvnS6K/R7YcNOnC3s1Fu4WPf//pWiElEUhHnaxPne2PQqAk72d8AjRBR6NdAjzPLW9k6XwbHymAn+6uQCJ/x9fublax49l23hkW2sqDQA+xk0ysLGBfZt0ANngP56SPdjnAPwFLakqxwXmOgNUel0KJccLcMbQzUijlGmrSdbHC31LgjuFvyNVDD4Rlrwk726pDo55nzebrtt6ADO9nLQC8/KhRtOiUaGoc+ET3jIlhDZNp1lm73JQZ3+wfLohUOdw5ovtmYaGgc+otEr0SiPwE1ttqQhJ3sP3zPR2QNtX48wX3cJIuAxqGNotx212MTdwuNQ1sBNTaIVMDd/tWRIQZDM7j7XGgc4md41h3y/TNhJ3tjoHzLf9A4tD3QmmP5DxqHBAC1PG4uEdytCKBGysspQuOQGKCcyn+wky0KKPoxrZjtkLdq2MkWBdQ4/pT3Tzvk0eEYxw40DgkDevglFR33Dp1qx3Nq2CgTCfSnLZd+h7xVp/+3dza6jepAGEWWG+vWyHVZVoKK93/O6zGQn0ILKs42ds4nRatkE0M5zNiYz8Pb2+sLI9vfBnpk+u/Kf/v29v7BOOgRgB6Y/rt2yNNrPgrQI47rZ3voeR5ADziun+qh59kAPTD99/o8Dz3PCOieWy6r8wf6dHqeh57nBHR7+m91hX18YM7Lszz0PCegm47r1bVHOKcfFujm9N/aCvsP1gU+LtCt6b/l1Yl+xSv0wEA3pv+WK+w1C48eG+jG9N/nCFXcHXtwoBvTf5/mD/5gRnh0oBvTf7ej3A8Wkj0+0I3pv6v5A/2KuSQDoFsFF87zB6zDzgPoXsc1w6FcgO4ruPDkj5vLCeiuggusq88H6I6CC/qd4VBGQDdvuagTC3dzArrl/mM4lBvQ76f/GA5lB/TbggvcXMkPaCy4sG5AYDiUJdCQc9cf5sBwKE+g6m29zO1fhkN5Aq1Oqw9zYDiULdCPNSM8w6F8gf5dPsyBwhc5A12awdSJwhePC3RbV1aT6en1vUGp9AsR+ud2lIt3KPeUW71fL1VhOJQ/0Jf380wR1tsSgF5uuSjqgBUBdL7l8sJKpDKATo5rymiWAnR0XDMcKgfoxyvDoaKAqv+4uVIU0OpE0f+ygL6wMLssoAig6N6ygzEtQItRY5wiQguSM5aUW5C0Mc6YGqAFAdUhSv0M8l53zNG/UmtUVS9CFKDZqgvRuexHAZozUdNa+lAmFlBuQK3lOBQE1PY9QAsCCs6SZHsDzpJwjtFJH1oWTpJuIUDBWW6UomJwMrFQWHQCtLA+FKCFCaAARQBFAEVb0oMxjhvc5WgwVretBmghUuL6G/AUFaNGlkF0ZxsnQAsDii+30JSLch4UqeWgCBV22YIQQuj3RAXbrMvlrgCloSx3CaAApSGAAhSgAAUoQAEKUBrKFShCCCGEEEKlqTam9QnasfJEyjrFHqkutNQcb0eHdlKsbo5mu6pxa2XZftCQjzfR/L14+gDBpTCS1WEXk1RY0X2bxjYjhsf++JnRjlXBfR327FBrc0PG3TNAhYFPE1lVisNXrdQP/fEBbJI01pzLvA/HAqv5F0Dlr/ZmSNNUEhROyjYPOsXp5QPQLh1Qe7AnuEq5dQ5Aq6tqy4casUk4xF7PJYzQwHNIc2Zod78+NGnKTZItxRpuU6WlFMODiUMYPTqdBmi6buWOg6LOyolnU+zRkOwPTpJ7Rg718X5gasgnOlB3vmyRriFNCSSfqI+xadppxz6vjlcb7nhD6Q4UQgghhBBCCCGEEEIIIYQQQgih+2swP7tnr5M4dnc6Iux9/XnZyI71eNzFQrPylR9aQ74AutyUlU/8F16zvaTq+3m5MtOWZ+bHnqHdEWq/PpskP+xrRLc9LC9AJWy8cYNxNrxUXJownvISw21gE7jq6cHvbXhjvJ/XCDhT905LoA86vOmcOO4aZ1oBKqsuwsed6XozhDdD3FQ3en7E+9PaJvp3JEKnDQTA9XkBQuTURwPr6PHpZIuSVMYNx89GZ1gDzM9Aw1FxcVmCxMXkrRffbcRVi0NVvt0aq0K/OudONxuyhuhKrKPlN/xYItSaPibNLnzcx1cz/WxKDIGmOqfcaQPhvZ6jtomZuB5/6sP/T1WifWg4bvhsbvfk3AXQLtILL2Uuq3QmoI0UaVbx0LYjrDmljk5k38focfGY1wJS/l++Hv5VXUQVX7PTMvyoiZHazEDnDcj7RipCxwRRR6x9E8D1ca+6KmQRicq44ZBBXN0AdBOouvShe4CGQNH1fqDjEKg1Xm8AHSM0BL+4zPs5qtv4m+lMksStAPotUOkKox/7Gmh1SblLoHXoHYcLUB2+o25S7g3QJuZJaaAxUxK+TblnoGMfKnHYy0ZC7+wjcH8GWo1nGn3ot0C1nPaDugV6GRQtgaq4OOUMNGbCm0HRDVDp/eIWxy8Ni0HRBeg0yu3HaGyj8Vmqf89A68kLzSg3mytlF4Nwqx4/16G5KF4Hby5xY6YIIYQQQgghhBBCCCGE0Kz/AYEqR6Qby6HRAAAAAElFTkSuQmCC"/></div><div class="graphic_lgnd">Glycemic control, estimated from the median hemoglobin A1C value, in patients with type 2 diabetes mellitus in the United Kingdom Prospective Diabetes Study (UKPDS) who were randomly assigned to receive intensive therapy with a sulfonylurea or insulin or to conventional treatment with diet; drugs were added if there were hyperglycemic symptoms or if the fasting blood glucose concentration was greater than 270 mg/dL (15 mmol/L). The A1C values were lower in the intensive therapy group but rose in both groups over time. The circles represent data for all patients, while the lines represent data for patients followed for 10 years.</div><div class="graphic_footnotes">A1C: HbA1c, glycated hemoglobin.</div><div class="graphic_reference">Data from: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352:837.</div><div id="graphicVersion">Graphic 81706 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
